Urokinase 3D Structures: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 19: | Line 19: | ||
**[[6ag7]] - hUK + pyrazine inhibitor<br /> | **[[6ag7]] - hUK + pyrazine inhibitor<br /> | ||
**[[5za8]], [[5za9]], [[5zae]], [[5zaf]], [[5zag]], [[5zah]], [[5zaj]], [[5zc5]], [[6ag2]], [[6ag3]], [[6ag9]], [[6jyp]], [[6jyq]], [[6l04]], [[6l05]] - hUK (mutant) + pyrazine inhibitor<br /> | **[[5za8]], [[5za9]], [[5zae]], [[5zaf]], [[5zag]], [[5zah]], [[5zaj]], [[5zc5]], [[6ag2]], [[6ag3]], [[6ag9]], [[6jyp]], [[6jyq]], [[6l04]], [[6l05]] - hUK (mutant) + pyrazine inhibitor<br /> | ||
**[[1fv9]], [[1gi7]], [[1gi8]], [[1gi9]], [[1gjb]], | **[[1fv9]], [[1gi7]], [[1gi8]], [[1gi9]], [[1gjb]], [[1gjc]], [[1o3p]], [[1o5c]] – hUK (mutant) + benzimidazole derivative <br /> | ||
**[[5yc6]], [[5yc7]], [[5z1c]] - hUK (mutant) + benzylamine derivative<br /> | **[[5yc6]], [[5yc7]], [[5z1c]] - hUK (mutant) + benzylamine derivative<br /> | ||
**[[1f5k], [[2o8u]], [[6ag2]], [6ag3 | **[[1f5k], [[2o8u]], [[6ag2]], [[6ag3]] - hUK (mutant) + benzamidine derivative<br /> | ||
**[[1f5l]] - hUK (mutant) + amiloride derivative<br /> | **[[1f5l]] - hUK (mutant) + amiloride derivative<br /> | ||
**[[1owd]], [[1owe]], [[1owh]], [[1owi]], [[1owj]], [[1owk]], [[1sqa]], [[1sqo]], [[1u6q]], [[1sqt]], [[4fuc]], [[4fud]], [[4fue]], [[4fuf]], [[4fug]], [[4fuh]], [[4fui]], [[4fuj]]- hUK + naphthamidine inhibitor<br /> | **[[1owd]], [[1owe]], [[1owh]], [[1owi]], [[1owj]], [[1owk]], [[1sqa]], [[1sqo]], [[1u6q]], [[1sqt]], [[4fuc]], [[4fud]], [[4fue]], [[4fuf]], [[4fug]], [[4fuh]], [[4fui]], [[4fuj]]- hUK + naphthamidine inhibitor<br /> |
Revision as of 10:16, 10 January 2021
3D Structures of urokinase3D Structures of urokinase
Updated on 10-January-2021 - For a general description of the protein see Urokinase {{#tree:id=OrganizedByTopic|openlevels=0|
- Urokinase' Domains - N terminal 21-163; Kringle 69-153; catalytic 179-431
- Urokinase catalytic domain complex with inhibitors
- 1c5w, 1c5x, 1c5y, 1c5z, 3ig6, 4fu7, 4fu8, 4fu9, 4fub - hUK + inhibitor
- 1f92, 1gj7, 1gj8, 1gj9, 1gja, 1gjd, 1o5a, 1o5b, 1sc8, 1vj9, 1vja, 3kgp, 3khv, 3kid, 3mhw, 3mwi, 4h42, 5wxs, 5wxt - hUK (mutant) + inhibitor
- 6ag7 - hUK + pyrazine inhibitor
- 5za8, 5za9, 5zae, 5zaf, 5zag, 5zah, 5zaj, 5zc5, 6ag2, 6ag3, 6ag9, 6jyp, 6jyq, 6l04, 6l05 - hUK (mutant) + pyrazine inhibitor
- 1fv9, 1gi7, 1gi8, 1gi9, 1gjb, 1gjc, 1o3p, 1o5c – hUK (mutant) + benzimidazole derivative
- 5yc6, 5yc7, 5z1c - hUK (mutant) + benzylamine derivative
- [[1f5k], 2o8u, 6ag2, 6ag3 - hUK (mutant) + benzamidine derivative
- 1f5l - hUK (mutant) + amiloride derivative
- 1owd, 1owe, 1owh, 1owi, 1owj, 1owk, 1sqa, 1sqo, 1u6q, 1sqt, 4fuc, 4fud, 4fue, 4fuf, 4fug, 4fuh, 4fui, 4fuj- hUK + naphthamidine inhibitor
- 6nmb- hUK + tranexamic acid inhibitor
- 1ejn - hUK (mutant) + urea derivative inhibitor
- 2vin, 2vio, 2vip, 2viq, 2viv, 2viw - hUK (mutant) + mexiletine derivative
- 6xvd, 1lmw - hUK + peptide inhibitor
- 3ox7, 3oy5, 3oy6, 3qn7, 4jk5, 4jk6, 4x1n, 4x1q, 4x1r, 4x1s, 4x0w, 4x1p, 4zhl, 4zhm, 4zkn, 4zko, 4zkr, 4zks, 5wxo, 5wxp, 5wxq, 5wxr, 5wxf - hUK (mutant) + peptide inhibitor
- 2nwn, 3m61, 4gly, 4mnw, 4mnv, 4mnx, 4mny, 4os1, 4os2, 4os4, 4os5, 4os6, 4os7 - hUK (mutant) + bicyclic peptide
- 2o8w, 2vnt, 2r2w - hUK + guanidine derivative
- 5xg4 - hUK + quercetin
- 1w0z, 1w10, 1w11, 1w12, 1w13, 1w14 - hUK + alanineamide derivative
- 6a8g, 6a8n - mUK (mutant) + cyclic peptide
- 1c5w, 1c5x, 1c5y, 1c5z, 3ig6, 4fu7, 4fu8, 4fu9, 4fub - hUK + inhibitor
- Urokinase complex with protein
- 2fd6 – hUK Hc N terminal + antibody + UK receptor
- 3bt1, 3bt2 - hUK Hc N terminal + vitronectin + UK receptor
- 4k24 - hUK Hc N terminal + vitronectin + antibody
- 3laq, 3u73 - hUK Hc N terminal + UK receptor
- 2i9b - hUK Hc N terminal + UK receptor (mutant)
- 3pb1 - hUK Hc catalytic domain (mutant) + UK inhibitor
- 4dw2 - hUK B chain catalytic domain + antibody
- 5hgg - hUK catalytic domain (mutant) + antibody
- 5lhn, 5lhr - mUK catalytic domain (mutant) + antibody
- 5lhp, 5lhq - mUK catalytic domain (mutant) + antibody + inhibitor
- 2fd6 – hUK Hc N terminal + antibody + UK receptor
}}